Epidemiological analysis of Borna Disease Virus 1 (BoDV-1) in patients after solid organ transplantatio
- Conditions
- G05.1Z94Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhereTransplanted organ and tissue status
- Registration Number
- DRKS00025180
- Lead Sponsor
- niversitätsklinikum Regensburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 496
Inclusion Criteria
solid organ transplantation
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method seroprevalence of BoDV-1
- Secondary Outcome Measures
Name Time Method correlation between sero-positivity and clinical symptoms
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link BoDV-1 to post-transplant neurological complications in solid organ recipients?
How does BoDV-1 prevalence in transplant patients compare to other viral pathogens like JC or BK virus?
Which biomarkers correlate with BoDV-1 reactivation in immunosuppressed solid organ transplant recipients?
What are the long-term neurological adverse events associated with BoDV-1 infection after organ transplantation?
Are antiviral therapies or immunosuppression adjustments effective in managing BoDV-1-related encephalitis post-transplant?